DJIA 17,776.91 93.33 0.53%
NASDAQ 4,997.46 5.52 0.11%
S&P 500 2,081.34 12.58 0.61%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

55.36 -0.07 (-0.13%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ISIS $55.36 -0.13%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $55.57
Previous Close $55.43
Daily Range $53.56 - $55.96
52-Week Range $27.37 - $77.80
Market Cap $6.6B
P/E Ratio -277.15
Dividend (Yield) $0.00 (0.0%)
Volume 2,259,920
Average Daily Volume 2,545,831
Current FY EPS -$0.26

Sector

Healthcare

Industry

Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/

News & Commentary

3 Biotech Stocks to Buy As the Greek Tragedy Unfolds

Exelixis, Enanta Pharmaceuticals, and Isis Pharmaceuticals are three names in biotech I'm closely watching in case they fall as a result of the financial crisis in Greece.

Isis Pharmaceuticals' Lipid Disorder Drug Gets Orphan Status - Analyst Blog

Isis Pharmaceuticals' Lipid Disorder Drug Gets Orphan Status - Analyst Blog

Sector's Smaller Players Show The Way

Strong Upward Pre-Market Activity For ISIS Pharmaceuticals (ISIS)

Should Isis Pharmaceuticals (ISIS) Be On Your Radar Now? - Tale of the Tape

Isis Pharmaceuticals Inc. Investors Can Finally Sense a Bright Future

After decades of zero return, Isis Pharmaceuticals' stock has been on fire recently. Is it smart to jump on board now?

Commit To Purchase Isis Pharmaceuticals At $33, Earn 9.1% Using Options

Isis Pharmaceuticals Up on Spinal Muscular Atrophy Data - Analyst Blog

ISIS Pharma Still Undervalued, Needham Says

IWM, CRBN: Big ETF Inflows

See More ISIS News...

ISIS's Top Competitors

ISIS $55.36 (-0.13%)
Current stock: ISIS
AMGN $155.39 (0.58%)
Current stock: AMGN
GILD $115.13 (-0.46%)
Current stock: GILD
BIIB $408.06 (0.85%)
Current stock: BIIB